Meijer C. Children from coeliac families benefit from early diagnosis and treatment: an analysis of the PreventCD cohort. UEG Week 2018, OP111.
Perioperatief camrelizumab plus rivoceranib bij resectabel HCC met gemiddeld-hoog recidiefrisico
dec 2025 | Chirurgie, Maag-darm-leveroncologie